These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2494741)

  • 1. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia.
    Sourek K; Tovarys F
    Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced survival in a rat glioma model following BNCT.
    Clendenon NR; Barth RF; Goodman JH; Staubus AE; Gordon WA; Moeschberger ML; Alam F; Soloway AH; Fairchild RG; Slatkin DN
    Strahlenther Onkol; 1989; 165(2-3):222-5. PubMed ID: 2494736
    [No Abstract]   [Full Text] [Related]  

  • 3. Canine spontaneous brain tumors--a large animal model for BNCT.
    Gavin PR; Kraft SL; Wendling LR; Miller DL
    Strahlenther Onkol; 1989; 165(2-3):225-8. PubMed ID: 2494737
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative microscopic study on response of Ehrlich carcinoma to BNCT vs. chemo- and radiotherapy.
    Samarrai SF; al-Mufti AW; Hikmat S; Karim JM; al-Hayani R; Sugano H; Saito T; Tsukagoshi S; Amano K; Hatanaka H
    Strahlenther Onkol; 1989; 165(2-3):217-8. PubMed ID: 2494734
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological efficacy of thermal neutrons using Na2(10)B12H11SH studied in vivo on B-16 mouse melanoma.
    Spryshkova R; Naidenov M; Borisov G; Komkov M; Bratsev V; Serebryakov N; Demidov A
    Strahlenther Onkol; 1989; 165(2-3):213-5. PubMed ID: 2494732
    [No Abstract]   [Full Text] [Related]  

  • 6. Boron determination for neutron capture therapy by colorimetry and emission spectrometry.
    Strouf O; Mertenová E; Schneiderová L; Zámecníková H; Janků I
    Strahlenther Onkol; 1989; 165(2-3):174-6. PubMed ID: 2494723
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological efficacy of a boronated porphyrin as measured in cell culture.
    Laster BH; Kahl SB; Kalef-Ezra J; Popenoe EA; Fairchild RG
    Strahlenther Onkol; 1989; 165(2-3):203-5. PubMed ID: 2494728
    [No Abstract]   [Full Text] [Related]  

  • 8. Accumulation of boron-10 (10B) in cell cultures exposed to mercaptododecaborate (Na2H(11)10B12SH) used for the neutron capture therapy of brain tumors.
    Mares V; Baudysová M; Kvítek J; Hnatovicz V; Cervená J; Vacík J; Folbergrová J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):818-22. PubMed ID: 1501124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three cases of terminal stage malignant gliomas in which the diffusely disseminated intraventricular tumors became the target of boron neutron capture therapy.
    Montagno Ede A; Moreira Filho L; Hatanaka H
    Strahlenther Onkol; 1989; 165(2-3):238-40. PubMed ID: 2494740
    [No Abstract]   [Full Text] [Related]  

  • 10. Monte Carlo treatment planning and high-resolution alpha-track autoradiography for neutron capture therapy.
    Zamenhof RG; Clement S; Lin K; Lui C; Ziegelmiller D; Harling OK
    Strahlenther Onkol; 1989; 165(2-3):188-92. PubMed ID: 2494725
    [No Abstract]   [Full Text] [Related]  

  • 11. Boron neutron capture therapy at the crossroads: challenges and opportunities.
    Barth RF
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BNCT project in Czechoslovakia.
    Burian J; Janku I; Kvitek J; Mares V; Prouza Z; Spurny F; Sourek K; Stibr B; Strouf O
    Basic Life Sci; 1989; 50():39-48. PubMed ID: 2751618
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose bracketing in boron neutron capture therapy.
    Gahbauer R; Kanellitsas C; Blue T; Wang C; Clendenon N; Fairchild R; Laster B; McGregor J; Goodman J
    Strahlenther Onkol; 1989; 165(2-3):229-30. PubMed ID: 2494738
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of boron in two (B12H11SH)2--infused patients with malignant glioma.
    Slatkin DN; Finkel GC; Micca PL; Laster BH; Poletti CE; Sweet WH
    Strahlenther Onkol; 1989; 165(2-3):244-6. PubMed ID: 2928948
    [No Abstract]   [Full Text] [Related]  

  • 15. Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.
    Gibson CR; Staubus AE; Barth RF; Yang W; Kleinholz NM; Jones RB; Green-Church K; Tjarks W; Soloway AH
    Drug Metab Dispos; 2001 Dec; 29(12):1588-98. PubMed ID: 11717178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head phantom experiment and calculation for NCT using various neutron beams.
    Matsumoto T; Aizawa O
    Strahlenther Onkol; 1989; 165(2-3):98-100. PubMed ID: 2494756
    [No Abstract]   [Full Text] [Related]  

  • 17. A multidisciplinary program leading to a clinical trial of neutron capture therapy at Tufts-New England Medical Center and the Massachusetts Institute of Technology.
    Zamenhof RG; Madoc-Jones H; Harling OK; Bernard JA
    Strahlenther Onkol; 1989; 165(2-3):254-7. PubMed ID: 2538941
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of tumor growth in a glioma model treated with boron neutron capture therapy.
    Goodman JH; McGregor JM; Clendenon NR; Gahbauer RA; Barth RF; Soloway AH; Fairchild RG
    Neurosurgery; 1990 Sep; 27(3):383-8. PubMed ID: 2234330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The physical tests for realization of neutron capture therapy in Czechoslovakia.
    Burian J
    Strahlenther Onkol; 1989; 165(2-3):72-5. PubMed ID: 2494747
    [No Abstract]   [Full Text] [Related]  

  • 20. Fast neutrons for BNCT.
    Wagner FM; Koester L
    Strahlenther Onkol; 1989; 165(2-3):115-7. PubMed ID: 2494712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.